Gambogenic acid alleviates kidney fibrosis via epigenetic inhibition of EZH2 to regulate Smad7-dependent mechanism

Phytomedicine. 2022 Nov:106:154390. doi: 10.1016/j.phymed.2022.154390. Epub 2022 Aug 11.

Abstract

Background: Epigenetics regulating gene expression plays important role in kidney fibrosis. Natural products originating from diverse sources including plants and microorganisms are capable to influence epigenetic modifications. Gambogenic acid (GNA) is a caged xanthone extracted from gamboge resin, exudation of Garcinia hanburyi Hook.f., and the effect of GNA on kidney fibrosis with its underlying mechanism on epigenetics remains unknown.

Purpose: This study aimed to explore the role of GNA against kidney fibrogenesis by histone methylation mediating gene expression.

Methods: Two experimental mice of unilateral ureteral obstruction (UUO) and folic acid (FA) were given two dosages of GNA (3 and 6 mg/kg/d). TGF-β1 was used to stimulate mouse tubular epithelial (TCMK-1) cells and siRNAs were transfected to verify the underlying mechanisms of GNA. Histological changes were evaluated by HE, MASSON stainings, immunohistochemistry and immunofluorescence. Western blot and qPCR were used to measure protein/gene transcription levels.

Results: GNA dose-dependently alleviated UUO-induced kidney fibrosis and FA-induced kidney early fibrosis, indicated by the pathology and fibrotic factor changes (α-SMA, collagen I, collagen VI, and fibronectin). Mechanically, GNA reduced enhancer of zeste homolog 2 (EZH2) and H3K27me3, promoted Smad7 transcription, and inhibited TGF-β/Smad3 fibrotic signaling in injured kidneys. Moreover, with TGF-β1-induced EZH2 increasing, GNA suppressed α-SMA, fibronectin and collagen levels in tubular epithelial TCMK-1 cells. Although partially decreasing EZH2, GNA did not influence fibrotic signaling in Smad7 siRNA-transfected TCMK-1 cells.

Conclusion: Epigenetic inhibition of EZH2 by GNA ameliorated kidney fibrogenesis via regulating Smad7-meidated TGF-β/Smad3 signaling.

Keywords: EZH2; Gambogenic acid; H3K27me3; Kidney fibrosis; Smad7.

MeSH terms

  • Animals
  • Biological Products* / pharmacology
  • Enhancer of Zeste Homolog 2 Protein / genetics
  • Enhancer of Zeste Homolog 2 Protein / metabolism
  • Epigenesis, Genetic
  • Fibronectins / metabolism
  • Fibrosis
  • Folic Acid / metabolism
  • Histones / metabolism
  • Kidney
  • Kidney Diseases* / metabolism
  • Mice
  • RNA, Small Interfering / pharmacology
  • Transforming Growth Factor beta1 / metabolism
  • Ureteral Obstruction* / pathology
  • Xanthenes
  • Xanthones* / pharmacology

Substances

  • Biological Products
  • Fibronectins
  • Histones
  • RNA, Small Interfering
  • Transforming Growth Factor beta1
  • Xanthenes
  • Xanthones
  • Folic Acid
  • neo-gambogic acid
  • Enhancer of Zeste Homolog 2 Protein